Overview
Markus Glass practices in Halle, Germany. Mr. Glass is rated as an Advanced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Chronic T-Cell Leukemia (CTCL), Prolymphocytic Leukemia, Pancreatic Cancer, and Adult T-Cell Leukemia.
His clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Chronic T-Cell Leukemia (CTCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic T-Cell Leukemia (CTCL)Mr. Glass isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Prolymphocytic LeukemiaMr. Glass isAdvanced. Learn about Prolymphocytic Leukemia.
- Experienced
- Adult T-Cell LeukemiaMr. Glass isExperienced. Learn about Adult T-Cell Leukemia.
- LeukemiaMr. Glass isExperienced. Learn about Leukemia.
- Ovarian CancerMr. Glass isExperienced. Learn about Ovarian Cancer.
- Pancreatic CancerMr. Glass isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Ductal AdenocarcinomaMr. Glass isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.
- RUNX1 Familial Platelet DisorderMr. Glass isExperienced. Learn about RUNX1 Familial Platelet Disorder.